| Literature DB >> 31063584 |
Won Jin Lee1, Sun Ah Ham1, Gyeong Hee Lee1, Mi-Jung Choi1, Hyunjin Yoo2, Kyung Shin Paek3, Dae-Seog Lim4, Kwonho Hong2, Jung Seok Hwang1, Han Geuk Seo1.
Abstract
Neuronal expression of beta-secretase 1 (BACE1) has been implicated in the progression of Alzheimer's disease. However, the mechanisms that regulate BACE1 expression are unclear. Here, we show that peroxisome proliferator-activated receptor delta (PPARδ) decreases BACE1 expression by up-regulating suppressor of cytokine signaling 1 (SOCS1) in SH-SY5Y neuroblastoma cells. The activation of PPARδ by GW501516, a specific PPARδ agonist, inhibited expression of BACE1. This effect was abrogated by shRNA-mediated knockdown of PPARδ and by treatment with the PPARδ antagonist GSK0660, indicating that PPARδ is involved in GW501516-mediated suppression of BACE1 expression. On the other hand, GW501516-activated PPARδ induced expression of SOCS1, which is a negative regulator of cytokine signal transduction, at the transcriptional level by binding to a PPAR response element in its promoter. This GW501516-mediated induction of SOCS1 expression led to down-regulation of BACE1 expression via inactivation of signal transducer and activator of transcription 1. GW501516-activated PPARδ suppressed the generation of neurotoxic amyloid beta (Aβ) in accordance with the decrease in BACE1 expression. Taken together, these results indicate that PPARδ attenuates BACE1 expression via SOCS1-mediated inhibition of signal transducer and activator of transcription 1 signaling, thereby suppressing BACE1-associated generation of neurotoxic Aβ.Entities:
Keywords: Alzheimer's disease; BACE1; PPARδ; SOCS1; STAT1; amyloid beta
Mesh:
Substances:
Year: 2019 PMID: 31063584 DOI: 10.1111/jnc.14715
Source DB: PubMed Journal: J Neurochem ISSN: 0022-3042 Impact factor: 5.372